SQI Diagnostics Inc SQD

TVX: SQD | ISIN: CA78466B1085   14/06/2023
0,015 CAD (0,00%)
(0,00%)   14/06/2023

16 juni 2023 · SQI Diagnostics Announces Receipt of Intention to Enforce Security from Pivot Financial and Anticipated Voluntary Bankruptcy Filing · Persbericht

6 juni 2023 · SQI Diagnostics Reports Internal Restructuring · Persbericht

31 mei 2023 · SQI Diagnostics Reports Second Quarter 2023 Results · Persbericht

28 maart 2023 · SQI to Focus on Development of Point of Care Products In Respiratory Health · Persbericht

24 maart 2023 · Sqi Diagnostics Announces Proposed Insider Sales And Warrant Exercises To Fund Company · Persbericht

13 maart 2023 · SQI Diagnostics Announces New Capital Markets Consulting Agreement · Persbericht

3 maart 2023 · Four Diagnostic Products in the Pipeline at SQI · Persbericht

2 maart 2023 · SQI Diagnostics Reports First Quarter 2023 Results · Persbericht

31 januari 2023 · SQI Diagnostics Reports Fourth Quarter and Fiscal 2022 Results · Persbericht

18 januari 2023 · SQI installs two RALI-DX systems in Toronto hospitals to fight the growing respiratory health crisis in Emergency Departments · Persbericht

10 november 2022 · SQI Diagnostics Secures Up To $2 Million in FedDev Ontario Funding · Persbericht

19 oktober 2022 · Sqi Diagnostics Extends Maturity Date Of Pivot Credit Facility And Announces Deferral Of Certain Interest Payments · Persbericht

17 oktober 2022 · /C O R R E C T I O N from Source -- SQI Diagnostics Inc./ · Persbericht

17 oktober 2022 · SQI Diagnostics Announces Health Canada Approval of RALI-Dx Severity Triage Test · Persbericht

31 augustus 2022 · SQI Diagnostics Announces Grant of Stock Options · Persbericht

29 augustus 2022 · SQI Diagnostics Reports Third Quarter 2022 Results · Persbericht

Mijn selecties